Literature DB >> 1698028

Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.

P Gaulard1, P Bourquelot, P Kanavaros, C Haioun, J P Le Couedic, M Divine, M Goossens, E S Zafrani, J P Farcet, F Reyes.   

Abstract

Fifty-seven cases of peripheral T-cell lymphoma were studied for cell expression of the T-cell receptor (TCR) chains, using monoclonal antibodies specific for the beta chain (beta F1) of the alpha/beta TCR, and for the delta chain (anti-TCR delta-1) of the gamma/delta TCR. Three different patterns were demonstrated: in 39 cases (69%), the phenotype (CD3+beta F1+TCR delta-1-) was that of most normal T cells. A second pattern was found on six cases (10%), which were of CD3+beta F1-TCR delta-1+ phenotype, and in which DNA analysis showed a clonal rearrangement of the delta locus in the five cases studied. It is suggested that these cases are the neoplastic counterpart of the small subpopulation of normal T cells that express gamma delta receptor. It is of considerable interest that these gamma delta lymphomas had unusual clinicopathologic presentations, as one case corresponded to a lethal midline granuloma and the five others to hepatosplenic lymphomas with a sinusal/sinusoidal infiltration in spleen, marrow, and liver. The fact that the distribution of the neoplastic gamma delta cells in the splenic red pulp resembles that of normal gamma delta cells reinforces the concept of a preferential homing of gamma delta T cells to this tissue. A third pattern (CD3 +/- beta F1-TCR delta-1-) was seen in 12 cases (21%), in which, by contrast to normal post-thymic T cells, no evidence of either alpha beta or gamma delta T cell receptor was found.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698028      PMCID: PMC1877506     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Immunochemical proof that a novel rearranging gene encodes the T cell receptor delta subunit.

Authors:  H Band; F Hochstenbach; J McLean; S Hata; M S Krangel; M B Brenner
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

Review 2.  Pathologic and clinical spectrum of post-thymic T-cell malignancies.

Authors:  E S Jaffe
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes.

Authors:  J E Sims; A Tunnacliffe; W J Smith; T H Rabbitts
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

5.  DNA analysis in the diagnosis of hemoglobin disorders.

Authors:  M Goossens; Y Y Kan
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta.

Authors:  J P Farcet; P Gaulard; J P Marolleau; J P Le Couedic; T Henni; M F Gourdin; M Divine; C Haioun; S Zafrani; M Goossens
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

7.  Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases.

Authors:  P Gaulard; E S Zafrani; P Mavier; F D Rocha; J P Farcet; M Divine; C Haioun; Y Pinaudeau
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

8.  Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas.

Authors:  L J Picker; M B Brenner; L M Weiss; S D Smith; R A Warnke
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

9.  Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes.

Authors:  P G Pelicci; D M Knowles; R Dalla Favera
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

10.  Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes.

Authors:  L L Lanier; S Cwirla; N Federspiel; J H Phillips
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  14 in total

1.  Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

Authors:  G K Przybylski; H Wu; W R Macon; J Finan; D G Leonard; R E Felgar; J A DiGiuseppe; P C Nowell; S H Swerdlow; M E Kadin; M A Wasik; K E Salhany
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Sialosylated Lewis chi expression in CD30-positive anaplastic large-cell lymphomas.

Authors:  K Kasai; Y Sato; S Kuwao; Y Kawakubo; H Inoue; T Kameya
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.

Authors:  Adriana Garcia-Herrera; Joo Y Song; Shih-Sung Chuang; Neus Villamor; Luis Colomo; Stefania Pittaluga; Tomas Alvaro; Maria Rozman; Jazmin de Anda Gonzalez; Ana Maria Arrunategui; Eva Fernandez; Elena Gonzalvo; Teresa Estrach; Dolors Colomer; Mark Raffeld; Philippe Gaulard; Elias Campo; Elaine S Jaffe; Antonio Martinez
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

4.  Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.

Authors:  Shigeo Toyota; Norihiko Nakamura; Kazuo Dan
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

5.  Hepatosplenic αβ T-cell lymphoma with myelodysplastic syndrome.

Authors:  Tomoiku Takaku; Keisuke Miyazawa; Goro Sashida; Nahoko Shoji; Takashi Shimamoto; Noritake Yamaguchi; Yoshikazu Ito; Shigeo Nakamura; Kiyoshi Mukai; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

6.  Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.

Authors:  Michiko K Oyoshi; Hiroshi Nagata; Nobuhiro Kimura; Yu Zhang; Ayako Demachi; Toshiro Hara; Hirokazu Kanegane; Yoshinobu Matsuo; Tomohiro Yamaguchi; Tomohiro Morio; Atsuyoshi Hirano; Norio Shimizu; Kohtaro Yamamoto
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 7.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

8.  Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.

Authors:  M L Boulland; V Meignin; K Leroy-Viard; C Copie-Bergman; J Brière; R Touitou; P Kanavaros; P Gaulard
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

10.  Occult hepatosplenic T-gamma delta lymphoma. Value of genotypic analysis in the differential diagnosis.

Authors:  C C Dommann-Scherrer; S B Kurer; D R Zimmermann; B F Odermatt; M T Dours-Zimmermann; J Briner; P U Heitz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.